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ABSTRACT
The lysX gene from Mycobacterium avium hominissuis (MAH) is not only involved in cationic
antimicrobial resistance but also regulates metabolic activity. An MAH lysX deficient mutant was
shown to exhibit a metabolic shift at the extracellular state preadapting the bacteria to the
conditions inside host-cells. It further showed stronger growth in human monocytes. In the
present study, the LysX activity on host–pathogen interactions were analyzed. The lysX mutant
from MAH proved to be more sensitive toward host-mediated stresses such as reactive oxygen
species. Further, the lysX mutant exhibited increased inflammatory response in PBMC and multi-
nucleated giant cell (MGC) formation in human macrophages during infection studies.
Coincidentally, the lysX mutant strain revealed to be more reproductive in the Galleria mellonella
infection model. Together, these data demonstrate that LysX plays a role in regulating the
bacillary load in host organisms and the lack of lysX gene facilitates MAH adaptation to intracel-
lular host-habitat, thereby suggesting an essential role of LysX in the modulation of host–
pathogen interaction.
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Humans come in contact with different mycobacterial
species as these are omnipresent in diverse environ-
mental niches [1]. Their competency to multiple adap-
tations enables many mycobacterial species to inhabit
a vast array of environmental habitats, including nat-
ural waters, soils, sawdust, and drinking water distribu-
tion systems [2]. One mechanism mediating adaptation
is the presence of a lipid-rich hydrophobic outer mem-
brane, which is a major determinant of surface adher-
ence, biofilm formation, aerosolization, and antibiotic/
disinfectant resistance [2,3].
Phylogenetically, the genus Mycobacterium is classi-
fied into three main groups: (i) obligate pathogens that
require a mammalian host such as Mycobacterium (M.)
tuberculosis (MTB) complex; (ii) opportunistic environ-
mental mycobacteria referred to as Nontuberculous
mycobacteria (NTM) and (iii) species that thrive in
a “strictly intracellular” niche such as the
Mycobacterium leprae [4]. The NTM can be further
divided into slow growers (e.g. M. avium complex
(MAC)) and rapid growers (e.g. M. abscessus).
Apart from M. tuberculosis (MTB) and M. leprae, the
slow-growing NTM are also frequently involved in
human disease [5,6]. Amongst them, the M. avium
subsp. hominissuis (MAH) poses a major risk to immu-
nocompromised patients, especially those who are
infected with HIV and have severe respiratory diseases
such as cystic fibrosis, bronchiectasis, and chronic
obstructive pulmonary disease (COPD) [7]. Subacute
or chronic lymphadenitis in the cervical region are the
most common manifestation of MAH in children [8].
MAC also causes lung disease very similar to tubercu-
losis, manifesting as apical fibrocavitary disease or
interstitial nodular infiltrates in immunocompetent
hosts and bronchiectasis [9]. In this manner, the clin-
ical symptoms of pulmonary infection by NTM are
similar to other pulmonary diseases, consequently the
NTM diseases are likely misdiagnosed and underre-
ported especially in developing countries, where TB
and AIDS are the major focus of the healthcare system
[10]. On account of the numerous types of NTMs being
typically resistant to antituberculosis drugs [5], it is
convincing that they are being misinterpreted as multi-
drug-resistant (MDR) MTB strains [11]. Recently it was
also reported that among the chronic TB and MDR-TB
patients from developing countries, 12–30% of them
were found to suffer from NTM infections [12]. This
eventually leads to inaccurate diagnosis contributing to
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disease progression and deterioration of the patient’s
health.
On the other hand, the incidence of NTM lung
diseases has also been increasing worldwide over the
past few decades [13] posing it to be a pathogen of
a global health threat. It was reported that NTM dis-
eases lead to a greater disease burden than TB in the
US, Canada, Japan, Korea, Australia, and the United
Kingdom [14–18]. For example, in England and
Ireland, the annual incidence rates of NTM diseases
was increased from 5.6/100,000 in the year of 2007 to
7.6/100,000 in 2012 [18]. Despite this, mechanisms of
pathogenicity for the heterogeneous group of NTM
remain scarce. Hence, there exists an urgency to dis-
cover the virulence mechanisms of these environmental
pathogens in order to improve the accuracy in diagno-
sis and relevancy in the treatment process. Although
several studies have exposed some knowledge on
the M. avium genes associated with pathogenesis,
a deeper understanding is still required about the
mycobacterial virulence determinants [19].
The multidrug resistance and the virulent nature of
the environmental pathogen Mycobacterium avium is
ascribed to the organism’s lipid-rich cell wall and its
colony morphology [20]. Several cell-wall associated
lipids are considered to be potential mediators of viru-
lence. For instance, M. avium expresses on its cell sur-
face serovar-specific glycopeptidolipids (ssGPLs) [21]
which are absent in MTB. These highly antigenic
GPLs have been involved in inhibiting macrophage
activation [22,23] and in immuno-modulatory activity
by downregulating Th1 type responses, thus benefiting
the pathogen’s intracellular survival [24,25]. In addi-
tion, by changing the pattern of GPL
expression M. avium can also modulate macrophage
inflammatory responses [24].
Studies on the lysX gene from MTB revealed that the
gene which is involved in the lysinylation of surface
phospholipids was responsible for the susceptibility
toward antimicrobial peptides in-vitro and for the sur-
vival of the pathogen in vivo [26]. These findings sug-
gest an association between the susceptibility of
pathogenic mycobacteria to antimicrobial peptides
and the components on the bacterial surface, whose
expression may also vary depending on the environ-
ment [27].
Unlike MTB, the M. avium survive in harsh environ-
ments including environmental hosts like free-living
amoebae and thus havemultifarious survival mechanisms
[7]. Additionally, it is also assumed to have a cell wall
which is harder to penetrate distinguishing M. avium
from MTB [27]. Thus, it is of key importance to under-
stand the interactions between the human host
andM. avium, and decode how theM. avium are capable
to survive host defense mechanisms. In our earlier experi-
ments, we had already evidenced that the gene lysX, which
is a lysyl-transferase-lysyl-tRNA synthetase fromMAH is
associated with resistance toward cationic antimicrobials
as well as having an immense impact on the carbohydrate
and lipid metabolism. Lack of lysX in MAH caused a shift
in metabolism, which reflected the intracellular metabolic
pattern of MTB amid infection, thereby improving the
ability to multiply within human monocyte-derived cells.
Notably, this behavior was contrasting to that of the lysX
mutant from MTB [28]. In this manuscript, we have
attempted to analyze the effect of the MAH lysX gene in
host–pathogen interactions. Interestingly, the lysX
mutant strain displayed increased reproducibility in
human monocytes and galleria larvae even though the
mutant remained sensitive to host-mediated stresses at
the extracellular level.
Materials and methods
Bacterial strains and growth conditions
The study was performed with the wild-type strain
MAH 104 [29], the LysX-deficient mutant lysXmut
and the complemented strain lysXcomp [28,30].
Middlebrook 7H9 broth (BD Biosciences) along with
0.05% Tween 80 was used to grow the mycobacterial
strains at 37°C and the media was supplemented with
10%-modified ADC (2% glucose, 5% BSA, 0·85%
NaCl). The strains were cultured without shaking at
37°C. Middlebrook 7H11 agar plates supplemented
with 10% modified ADC or OADC (oleic acid, albu-
min, dextrose, catalase; BD Biosciences) and 0.5%
Glycerol was also used for plating purposes.
Stress resistance test
H2O2 and NO exposure
The bacterial cultures were grown up to an OD of 1.8
and then were exposed to a single dose of H2O2 or the
NO donor DETA/NO (diethylenetriamine/nitric oxide
adduct). Doses of 20 mM and 100 mM H2O2 or 25 mM
DETA/NO were used. The ATP production of each of
the cultures was monitored after 4 h post addition of
stress. The ATP content was quantified using the lumi-
nescence-based kit BacTiter-Glo™ Microbial Cell
Viability Assay (Promega) as per the manufacturer’s
instructions. A microplate luminometer, TriStar LB
941 Multimode Microplate Reader (Berthold
Technologies) was used to measure the luminescence
as relative light units (RLU). All stress resistance tests
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were performed in triplicate and repeated indepen-
dently three times.
Exposure to human beta defensin-1
The activity of human beta defensin-1 against MAH
was determined by a 96-well microplate assay. 160 µl of
dilutions of human beta defensin-1 (Sigma-Aldrich)
and 40 μl log-phase bacteria (OD of 1.8) were added
to the microplate wells to obtain a final concentration
of 0.5 µg/ml or 1 μg/ml of peptide. The defensin was
dissolved in 0.01% acetic acid and 0.01% acetic acid was
added to the controls. After the exposition for 5 days at
37°C, ATP content was measured as aforesaid to check
the growth inhibitory activity of the peptide. The
experiments were performed in triplicate each being
repeated three times.
Quantification of cytokines produced by infected
human PBMCs
Human buffy coats were utilized to extract peripheral
blood mononuclear cells (PBMCs) by Ficoll-Paque (GE
Healthcare) gradient centrifugation as mentioned by
the manufacturer’s recommendations and method as
described elsewhere [31]. PBMCs were seeded in 24-
well cell culture plates (TPP) at 106 cells/well and incu-
bated at 5% CO2, 37°C for 24 h prior to stimulation
with bacteria. The PBMCs were infected with the bac-
terial strains at an MOI of 10 and were incubated for up
to 120 h at 5% CO2 at 37°C. Uninfected cells were used
as negative controls. The culture supernatants were
collected at 24 h and 120 h post infection and analyzed
for cytokine secretion by ELISA (Human IL-10, IL-1β,
IL-12(P40) & TNFα, ELISA Ready-SET-Go!™, Thermo
Fischer Scientific), in accordance with the manufac-
turer’s instructions. Cytokine quantifications were
repeated with three buffy coat PBMCs from different
donors including three replicates per repeat.
Glycopeptidolipid (GPL) extraction
GPLs were prepared as in accordance with methods as
described in [32,33]. The M. avium strains were culti-
vated in Middlebrook 7H9 broth with 0.05% Tween 80
(Becton Dickinson) supplemented with modified ADC
enrichment at 37°C. The bacterial strains were grown
up to a log phase of OD600 1.8–2.0, were heat-killed and
the GPL was extracted from the dried bacterial pellets.
In brief, the dried pellets (from 50 ml culture) were
extracted with 10 ml of chloroform-methanol (2:1, vol/
vol) involving ultrasonication (Branson sonifier-450 D,
G. Heinemann) at 100% power for 1 min. The liquid
phases were then hydrolyzed with 3 ml of 0.2 N sodium
hydroxide in methanol to remove alkali-labile lipids.
The lipid extracts were then neutralized to pH 7 using
6 N HCl. Chloroform (6 ml) was then added, shaken
well following the addition of water (5 ml) and centri-
fuged at 8000 g for 10 min. The bottom phase contain-
ing the organic solvent was pipetted into a new tube
and then evaporated completely. The alkali-stable lipids
were dissolved in chloroform-methanol (2:1) and
applied to silica-coated TLC plates (Analtech). The
GPLs were separated by thin-layer chromatography
(TLC) employing the solvent system of chloroform/
methanol (90:10, vol/vol). The GPLs were displayed
by spraying the plates with 10% H2SO4 in ethanol,
followed by the exposition of the plate to hot air.
GPL antigen – ELISA
The GPLs extracted from the bacterial strains were
diluted in PBS (1:1000) and 100 µl of the diluted
GPLs were added to a polystyrene microplate well
(Nunc MaxiSorp, Thermo Fischer Scientific). After
that, the plates were sealed and incubated overnight at
4°C. Nonspecific binding was blocked using 3% BSA
dissolved in PBS and then the wells were washed with
PBS. Serum from patients with or without MAH infec-
tion (approval from the ethics committee of the
Charité – Universitätsmedizin Berlin (EA2/093/12))
was diluted (1:1000) using 1% BSA dissolved in PBS
and 100 µl were applied to the appropriate wells which
contained the GPL extracts and incubated at room
temperature for an hour. GPLs without the exposure
to serum were used as a negative control. Then, the
plate was washed with PBS-Tween 20 and the wells
were treated with 100 µl of horseradish peroxidase
(HRP)-goat anti-human IgG (diluted to 1:5000 in 1%
BSA dissolved in PBS) as the secondary antibody. After
incubation for an hour, TMB ELISA substrate (Sera
care) was added and the reaction was stopped after 10
min by adding 0.16 M H2SO4. The absorption was
determined using a microplate reader (Infinite M200
PRO, Tecan) at 450 nm. All assays were performed in
triplicates and repeated with GPL preparations from
three independent cultures of each strain.
Measurement of fusion rates of infected human
monocyte-derived macrophages
The induction of the fusion of human monocyte-
derived macrophages (HMDM) upon infection with
mycobacteria has been described previously [34]. The
human monocytes were pre-activated with 100 U/mL
IFNγ and then infected at an MOI of 10. The infection
experiment was performed in imaging cell culture
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dishes (ibidi GmbH) consisting of labeled grids. The
ibidi dishes were employed as they facilitate good opti-
cal quality for high-resolution microscopy and the grids
aid in the quantification of multinucleated giant cells
(MGCs).
After 5-days postinfection, the culture samples were
fixed with 4% paraformaldehyde and then stained with
Nile red (25 mg in 2.5 ml of dimethyl sulfoxide) which
stains neutral lipids and DAPI (5 mg/ml (stock), 1:100
diluted in dimethyl sulfoxide) which stains DNA. The
stained preparation was evaluated using confocal laser
scanning microscopy (LSM780; Carl Zeiss). To deter-
mine the fusion index the numbers of nuclei per
macrophage were counted. Macrophages containing at
least three nuclei were considered as multi-nucleated
and the number of nuclei present in multi-nucleated
cells was also determined. At least 500 nuclei were
counted per preparation and the fusion index (FI) was
calculated using the formula:ref [34].
FI% ¼ Number of nuclei in multinucleated cell
Total number of nuclei
 100
The experiment was repeated five times with HMDM
from five buffy coats (different donors) including three
replicates each repeat.
Galleria mellonella infection
Galleria mellonella (Greater wax moth) larvae were
received from the animal breeding facility at the
Robert Koch Institute, Berlin, Germany. Larvae were
kept at 27°C. Healthy larvae were identified by their
cream color, without dark discoloration and larvae with
a bodyweight of approximately 250 mg were used in
infection experiments. For inoculation, the larvae were
injected by a 30G insulin syringe needle (Omnican,
Braun) in the hind leg with 106 bacteria in a volume
of 20 μl (n = 30 per group). After inoculation, the
infected larvae were kept individually (one larvae per
well) in 12-well cell culture plates in an alternate man-
ner and then were incubated at 37°C. The wells were
equipped with woodchips. Untouched larvae and PBS
injected worms served as control groups. The larvae
were checked every day for survival, pupation transi-
tions and death events were recorded. The survival
curve was performed in Graph Pad Prism.
Apart from quantifying the survival of infected
Galleria larvae we also quantified the survival of the
MAH strains within Galleria. Three to five living larvae
were used for homogenization and were freeze-killed at
−20°C immediately after inoculation to assess for uni-
form inoculation as well as actual bacterial infection
rate, and an equal number of larvae per group were
sacrificed after 5 and 10 days postinfection. Non-
melanized larvae were selected in order to obtain
a uniform test group. The sacrificed larvae were disin-
fected by wiping down with 70% ethanol and homo-
genized with glass beads (0.11 mm diameter; Sartorius)
in PBS-Tween 80 using a Precellys-24 tissue homoge-
nizer (Peqlab). CFU evaluation was carried out by
plating serial dilutions of the homogenized lysates in
duplicate on to Middlebrook 7H11 agar plates contain-
ing cycloheximide (25 µg/ml) and Vancomycin (2 μg/
ml) (Sigma) to inhibit the growth of intrinsic
G. mellonella flora. The mean CFU/ml of MAH surviv-
ing in G. mellonella was determined after 0, 5 and 10
days postinfection. In total, 150 larvae (30 per group)
were used per experimental trial and infection experi-
ments were repeated on three independent occasions.
Image processing
Images were adjusted for the appropriate dimensions,
for optimal brightness and contrast (applied to the
whole image), employing Photoshop Lightroom
(Adobe Systems).
Statistical analysis
All values mentioned in the results section are the mean
of at least three independent experimental repeats ±
SD. At least three technical replicates per repeat were
done. Experimental data were tested for statistical sig-
nificance at p < 0.05 using a Student’s t-test (Microsoft
Excel 2010) and graphically represented using
GraphPad Prism. The unpaired two-tailed Student’s
t-tests are reported for pair-wise statistics between the
strains (lysX mutant vs wild type and lysX mutant vs
lysX complement) which is provided in figure legends.
Results
LysX influences tolerance toward oxidative and
nitrosative stress
The effect of macrophage-mediated host defense
mechanisms such as reactive oxygen intermediates
(ROI) and reactive nitrogen intermediates (RNI)
against MAH was examined. The wild type, lysX
mutant and the lysX complemented strains, growing
in a mid-logarithmic phase were exposed to H2O2
concentrations of 20 mM and 100 mM. The ATP con-
tent of the cultures was determined after 4 h of incuba-
tion using the BacTiter-Glo™ Microbial Cell Viability
Assay with RLU (Relative Light Units) as readout.
Exposure to both the H2O2 concentrations resulted in
a considerable reduction in the cell viability of the lysX
mutant strain in comparison to the other strains.
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While, for example, the wild type was reduced from
100% RLU if not treated with H2O2 to 36% if treated
with 20 mM H2O2 for 4 h, the mutant was reduced to
17% by the same stress condition (Figure 1(a)). The
bacterial strains were also exposed to 25 mM NO donor
(DETA/NO) for a period of 4 h. Although with
a decrease to 51% in the wild type versus 42% in the
mutant the effect was less pronounced as for oxidative
stress, the lysX mutant strain again proved to be slightly
more sensitive toward the NO treatment (Figure 1(b)).
Absence of lysX slightly increases the susceptibility
to HBD-1 defensin
The antimycobacterial activity of the Human Beta
Defensin–I (HBD-I) belonging to the cationic antimi-
crobial peptide family against the three MAH strains
was examined. All strains showed a strong reduction in
cell viability after an exposure to 0.5 µg/ml of HBD-1
for 120 h. Compared to untreated cells (100% RLU) the
wild-type MAH 104 only showed a value of 17% after
exposure to HBD-I, the mutant was reduced to 10%
and the complemented strain to 21% (Figure 1(c)).
Thus, the lysX mutation had slightly increased the
defensin susceptibility of MAH 104.
The inflammatory and anti-inflammatory response
of MAH-infected human PBMCs is influenced by
lysX
In previous studies, we reported that the MAH lysX
mutant displayed an enhanced intracellular growth in
human blood-derived monocytes [28]. The observed
phenotypic trait may be affected by a differential host
inflammatory response. In order to analyze cytokine
production by PBMCs stimulated with the wild type,
the mutant, and the complemented strains (MOI 10),
the cell supernatants were harvested at 24 h and 120
h (120 h as the time point wherein the lysX mutant
showed an elevated intracellular growth in monocytes
[28]) after infection for quantification of the pro-
inflammatory cytokines IL-1β, IL-12(p40) and TNF-α
as well as the anti-inflammatory cytokine IL-10.
Comparatively, the lysX mutant strain induced more
pro-inflammatory and anti-inflammatory cytokine
secretion than the wild type at both the time points of
infection (Figure 2). Statistically significant differences
were observed for IL-1β, IL-12(P40) and IL-10, while
the differences for TNF-α were not statistically signifi-
cant. The differences in induction of cytokine secretion
between wild type and mutant were more pronounced
after 24 h compared to 120 h infection time.
LysX interferes with GPL expression and its
antigenic reactivity
GPLs are unique cell-wall molecules found in MAC
species and modulate the release of various proinflam-
matory mediators, such as prostaglandins, leukotrienes,
IL-1, IL-6, and TNF-α [25,35]. The ability of ssGPLs to
stimulate the release of proinflammatory mediators
appears to be structure-specific [35], and slight struc-
tural modifications can alter the way in which the GPL
interacts with host-cell receptors [36]. Since the lysX
gene is also associated with the membrane phospholi-
pid composition, the expression of GPL in the MAH
strains was also analyzed in this study. The effect of the
lysX mutation on GPL production was investigated by
analyzing purified alkali-stable lipids from bacterial cell
walls. The GPL expression pattern was visualized by
Figure 1. Sensitivity of MAH strains to hydrogen peroxide, nitric oxide, and defensin.
Survival of M. avium hominissuis wild type (MAH 104) (black bar), lysX mutant (open bar) and lysX complemented strain (striped bar)
bacteria after incubation with (a) 20 mM and 100 mM H2O2 for 4 h (b) 25 mM DETA/NO for 4 h or (c) 0.5 µg/ml Human Beta Defensin-1 for 5
days determined by measurement of ATP production using an luminescence-based assay. Data were normalized to untreated controls
(100% survival). Data are means ± standard deviation of the results from three independent experiments, each performed in triplicate (with
three cultures). Statistically significant differences in percentage survival relative to that of lysX mutant strain are indicated by asterisks (*,
P < 0.05; **, P < 0.01; ***, P < 0.0001; two-tailed, unpaired Student’s t-test)
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TLC. Representative results from the TLC analysis are
shown in Figure 3(a). The analysis of lipid extracts
from the wild type, mutant and complemented strains
revealed a different expression profile of GPL in the
mutant strain. The GPL bands were numbered (i to vi)
based on relative mobility on the TLC plate, with the
band (i) being the least polar (highest mobility on the
TLC plate). The bands (i-iii) appeared to be apparently
similar in all the three strains, but the band (v), a single
GPL band, with a lower TLC mobility seemed to be
lacking in the lysX mutant. The strain-specific GPL
band (iv) was also identified [37].
It has been depicted that the anti-GPL antibody levels
mirror the disease activity in MAC lung infections [38].
Therefore, the reactivity of sera from MAH-infected
patients with Cystic Fibrosis against the GPL extracts
from the MAH strains were tested by ELISA. As shown
in Figure 3(b), MAC patient sera showed a higher mean
absorbance value against GPLs extracted from the wild-
type (1.989) when compared to the lysX mutant strain
(1.588). The reactivity of the serum from a healthy person
was only slightly above the negative control.
LysX impacts the rate of macrophage fusion
MGCs are formed through the fusion of multiple
macrophages during chronic antigenic stimulation,
generated by virulent mycobacterial infections [39].
Since the lysX mutation was found to boost mycobac-
terial growth in monocytes [28], we tried to analyze the
impact of the lysX mutation on fusion events.
The HBDM were infected with bacterial strains at an
MOI of 10 and samples were fixed at the fifth day
postinfection for determination of the fusion index
Figure 2. Inflammatory cytokine secretions of human PBMC infected with M. avium strains.
Human blood-derived PBMCs were infected with the MAH strains (MOI 10) wild type (Black bar), lysX mutant (Open bar), lysX
complemented strain (striped bar) and pro-inflammatory (IL-1β (a), IL- 12 (b), TNF-α (c) and anti-inflammatory (IL-10 (d)) cytokines release
was measured by ELISA using the kits (ELISA Ready-SET-Go!™ Kit Thermo Fischer Scientific). Untreated cells (gray) were used as controls.
Three independent experiments were done in triplicates, and data shown are the mean with the standard deviation of the three
experiments. Statistically significant differences relative to that of lysX mutant strain are indicated by asterisks (*, P < 0.05; **, P < 0.01;
***, P < 0.0001; two-tailed, unpaired Student’s t-test).
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(FI). As shown in (Figure 4(a–d)), infection with the
mutant caused a FI of 23% while the wild type and the
complemented strain displayed a FI of 14% and 9%,
respectively. The fusion indexes of the uninfected con-
trols were always below 5%. Thus, the macrophages
infected with the lysX mutant strain induced more
MGC formation than the other two strains.
LysX affects the virulence of MAH
Galleria mellonella larvae were used as an in vivo model
to assess the difference in virulence potency of the three
MAH strains. Both, the survival of infected larvae as
well as the growth of MAH within the larvae were
investigated.
Larvae survival (n = 30 per group), in response to an
inoculum of MAH of 106 CFU per larva was deter-
mined over 18 days (Figure 5(a)). On observation, the
infected larvae showed more death events from the 12th
day postinfection. In comparison between the strains,
lysX mutant was highly virulent for Galleria, because
within 18 days all the animals infected with the lysX
mutant were killed. After 18 days following infection
only 40% mortality was recorded in the larvae group
infected with the wild-type MAH strain, whereas mor-
tality after infection with the lysX mutant was 100%. In
parallel, the lysX complemented strain showed an inter-
mittent behavior between wild type and the mutant
with 65% mortality. While more than 50% of larvae
survival was recorded for the wildtype (undefined med-
ian survival time), the mutant displayed a median sur-
vival time of 13 days and lysX complemented strain of
15 days, respectively. Conclusively, the lysX mutant
strain revealed to be more virulent than the wild type
with respect to the overall mortality of G. mellonella
larvae (Figure 5(a)). The survival of MAH (infection
dose 106 CFU) within G. mellonella was determined
over a period of 10 days postinfection. After infection
of G. mellonella larvae with the MAH strains, an
approximate 50% decrease in the bacterial numbers
was observed within 120 h. Anyhow, the bacterial
count in-vivo was elevated in all the three strains
between 120 h and 240 h postinfection. However, this
increase was most pronounced in the case of infection
by the lysX mutant. While the bacterial numbers upon
infection with the wild-type strain increased by a factor
of around tenfold during this time period, the bacterial
numbers for the lysX mutant increased around 100 fold
(Figure 5(b)). The lysX mutant thus displayed higher
replication rates within G. mellonella larvae than the
wild type.
Discussion
The lysX gene has been hypothesized to be correlated
with intracellular reproductivity and as an important
variable for the modulation of virulence
in M. tuberculosis [40]. This was postulated based on
Figure 3. GPL expression and immune reactivity of M. avium strains.
(a) Thin-layer chromatography (TLC) of GPL extracted from MAH strains wild type (Lane 1); lysX mutant (Lane 2) and lysX complemented
strain (Lane 3). Wild-type strain and lysX complemented strain both expressed similar GPL pattern whereas lysX mutant did not express one
GPL band (band v) at lower mobility position (indicated with dashed-red arrow). Serovar-specific (ss) GPLs (band iv) is marked with black
arrow [37]. (b) ELISA showing reactivity of sera from two MAH-infected patients against MAH GPL extracts from strains wild type (WT), lysX
mutant (lysXmut) and lysX complement (lysXcomp). GPL from lysXmut was less reactive to the MAC patient sera. Serum from a healthy
person was included as a control. Three independent experiments were done and repeated with GPL preparations from three independently
grown cultures per strain and the mean values are represented in the graph. Statistically significant differences relative to that of lysX
mutant strain are indicated by asterisks (*, P < 0.05; **, P < 0.01; two-tailed, unpaired Student’s t-test).
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a previous study which reported that the lysX mutant
from MTB exhibited a growth defect in THP-1 macro-
phages and in mouse lungs and was found to be atte-
nuated in guinea pig’s lungs [26]. It was also
demonstrated that a higher expression of lysX in MTB
strains was correlated with increased levels of intracel-
lular survival in both in vivo and in vitro and also
inducing more severe lesions related with pneumonia
[40], thus indicating lysX as a necessary factor for
acquiring full virulence.
Intriguingly, our studies on the lysX gene from
MAH revealed a different phenotype both in vivo and
in vitro. Bioinformatics comparison of the LysX protein
sequence of different mycobacteria and of the nucleic-
acid sequences of an extended lysX gene region
revealed differences both among different mycobacter-
ial species as well as among different strains from the
same species. As shown in supplementary Table S1 and
S2 the length of the LysX protein varies, mainly caused
by different length of the 5ʹ region of the gene. The
amino acid identity to the LysX protein from MAH 104
was 99% to MAH TH135 and 91% to MAH k10. The
phylogenetically more distant species M. tuberculosis
and M. leprae displayed identities of 77% and 82%,
Figure 4. Formation of multi-nucleated cells after infection of human blood-derived monocytes with M. avium strains.
Microscopic examination of human blood-derived monocytes infected (MOI 10) with M. avium strains (a) wild type (WT), (b) lysX mutant
(lysXmut) and (c) lysX complemented strain (lysXcomp) at 5 days postinfection. Fluorescence microscopic images showing multinucleated
giant cells (indicated with white arrows) generated by 4 million infected monocytes per culture dish. The cells were stained with Nile red
and DAPI, red fluorescence showing the Nile red staining of neutral lipids and blue fluorescence showing the DAPI staining of the
macrophage DNA. The stained samples were picturized using a confocal laser scanning microscope at a magnification of 100 × . Scale bars:
50 µM. (d) At least 500 nuclei were counted per sample to calculate the fusion index using the formula below [34]:
FI% ¼ Number of nuclei in multinucleated cell
Total number of nuclei
 100
Data are means ± standard deviation of the results from five independent experiments using buffy coats from five different donors. Statistically
significant differences relative to that of lysX mutant strain are indicated by asterisks (*, P < 0.05; two-tailed, unpaired Student’s t-test).
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respectively, to the MAH 104 LysX protein. Also, blast
analysis with the region containing the lysX gene from
MAH 104 and with other MAH and M. tuberculosis
strains demonstrated differences in gene sequence and
genome organization especially in the M. tuberculosis
strains (Fig. S1). These differences might have contrib-
uted to the diverging phenotypic effects of lysX muta-
tions in MAH and M. tuberculosis.
Phenotypic traits detected in M. avium indicate that
in contrast with those described in MTB, M. avium
adopts distinct strategies to manipulate the host
immune response and persist intracellularly. In this
context, we focused on studying the interference of
the MAH lysX gene on the host-pathogen interplay
and its contribution to the differential virulence
features.
The host mounts a complex response when infected
with mycobacteria to kill them or to limit their prolif-
eration. Reactive oxygen and nitrogen intermediates
(RONS) have been demonstrated as major antimicro-
bial molecules produced by the human host during the
course of infection with MTB [41]. Under extracellular
growth conditions, the lysX mutant from MAH proved
to be slightly more sensitive toward H2O2 and DETA-
NO. This behavior was in accordance with our previous
proteomics studies which showed that some of the
genes which are implicated in resistance toward
RONS were downregulated in the lysX mutant in com-
parison to the wild type and complemented strains
[28]. These include the genes encoding catalase (katG)
[42], alkyl hydroperoxide reductase (ahpC) and thioes-
terase family protein (MAV_2246). The ROS levels
induced by the host immune cells also determine the
ability of MTB to survive and replicate in the host [43].
However, this was not the case in Mycobacterium
avium complex (MAC) infections, wherein it was
shown that there was no significant relationship
between the degree of resistance to the host effector
molecules (RONS, free fatty acids (FFA)) and its viru-
lence in mice [44].
MAH is a pathogen that establishes infection by
crossing the respiratory and intestinal mucosas in
both humans and other mammals [27]. High concen-
trations of antimicrobial peptides (AMPs) are encoun-
tered by the bacterium in these mucus layers [45]. The
AMPs are an important component in host innate
response against bacteria and they are also released
intracellularly in phagocytic cells as in macrophages
and neutrophils [27]. The human beta defensin HBD-
1 plays a role in the innate immune defense against
MTB by permeabilisation of both the mycobacterial cell
wall and cell membrane [46]. Furthermore, significant
levels of β-defensins have been detected in bronchoal-
veolar lavage fluid from patients with M. avium infec-
tion [47]. We, therefore, attempted to assess the impact
of HBD-1 on the survival of MAH depending on the
presence of lysX. In-vitro testing with the M. avium
strains in response to HBD-1 showed a decrease in
the viability of the lysX mutant. This result goes well
with findings about the effect of MrpF (corresponding
Figure 5. Virulence of MAH in G. mellonella larvae.
(a) Survival of larvae infected with MAH. Larvae were infected with 106 CFU of the MAH strains wild type (WT), lysX mutant (lysXmut) or lysX
complemented strain (lysXcomp) on day 0. Controls were injected with PBS or were left untreated. Three different experiments using in
each experiment 30 larvae per group were performed. The survival and pupation of the larvae were checked every day. Pupation events are
indicated by short dashes. The graph shows the pooled survival percentages of the three experiments. (b) Quantification of bacterial growth
in vivo: 3 to 5 larvae per group were sacrificed, homogenized, and plated for CFU counts on days 0, 5 and 10, respectively. The data
represented are means ± standard deviation of the results from three independent experiments. Statistically significant differences relative
to that of lysX mutant strain are indicated by asterisks (*, P < 0.05; **, P < 0.01; ***, P < 0.0001; two-tailed, unpaired Student’s t-test)
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to the 5ʹend domain from LysX of MAH) from
Staphylococcus aureus. It was proven that staphylococ-
cal mprF confers resistance toward AMPs including
defensins [46]. MprF is a unique enzyme which con-
verts the anionic phospholipids to cationic lipids in the
bacterial membrane with l-lysine or l-alanine, thus
changing the membrane surface charge and shrinking
the affinity for cationic defensins [48]. Maloney and
colleagues have also demonstrated that in the absence
of the lysX gene, MTB becomes susceptible to AMPs
in vitro [26]. Cytokines are of vital importance in the
case of mycobacterial infections as they serve as effec-
tors and regulators of innate immune defense, also
determining the consequential adaptive T cell response,
yet their regulatory mechanism and their role in myco-
bacterial infections are still poorly understood [49]. The
induction of cytokine secretions are also driven
by M. avium morphotype and virulence [50]. Our eva-
luation of selected cytokine expression by freshly iso-
lated PBMCs infected with the MAH strains revealed
that the lysX mutant strain induced higher cytokine
levels (IL-1β, IL- 12, TNFα and IL-10) than the wild
type and complemented strains. MTB mutants which
lack the production of some cell-wall components (eg.
phenolic glycolipid (PGL), phthiocerol dimycocerosate
(PDIM)) also induce an increased secretion of the
proinflammatory cytokines TNF-α, IL-6, and IL-12
compared to the wild type [51]. The increased secretion
of inflammatory cytokines by the lysX mutant could be
partly explained by the fact that LysX already plays
a role in the production of membrane–bound lysylpho-
sphatidylglycerol. Moreover, using proteomic mass
spectrometry, we identified genes involved in glycero-
phospholipid metabolism (MAV_1825, fbpB, fbpC) and
GPL synthesis (MAV_4518, rmt4/mftb, fadE5, sap) that
were differentially regulated in the lysX mutant when
compared to the wild type and lysX complemented
strains.
Highly stimulated cells of macrophage lineage form
MGCs at a terminal stage of differentiation. MGC are
generally produced by cell–cell fusion [52,53] and it
was recently reported that the fusion process might be
triggered in a TLR2-dependent cell activation through
lipomannan from mycobacteria [54].
Upon the infection of IFNγ-activated HBDM with
the M. avium strains, the lysX mutant induced a higher
rate of macrophage fusion than the wild type and the
complemented strain. In correspondence, the gene
DprE1 which catalyzes the synthesis of cell-wall arabi-
nans was strongly overexpressed in the lysX mutant.
Besides the DprE1 was also illustrated to be essential
for the growth and survival of MTB [55].
It is evident from our experiments that lysX muta-
tion in MAH has an impact on several virulence attri-
butes. Further confirmation of a role of LysX for
virulence was obtained by performing in-vivo infection
experiments using the invertebrate infection model
G. mellonella. G. mellonella has a sophisticated innate
immune system which consists of cellular and humoral
defenses, which expose of a functional similarity to
vertebrates [56]. Recent reports have already demon-
strated the potentiality of employing a wax moth larvae
model for studying both slow and fast-growing myco-
bacteria infections such as M. bovis BCG
[57], M. abscessus [58], M. fortuitum [59], M. marinum
[59] and M. aurum [59].
In this study we have demonstrated the suitability of
G. mellonella as an infection model for MAH and also
employed this in-vivo model to assess the virulence of
our strains. The survival of both the host and mycobac-
teria was determined over a period after infection of 18
days or 10 days, respectively (Figure 5). Though the
strains did not show the same pattern of dying in all
the experimental trials, on comparison using the log-
rank test, the survival curves between wild type and
mutant were found to be significantly different (p <
0.0001). The lysX mutant strain was highly virulent,
killing 100% of larvae within a few days. In addition,
the mutated strain also featured a significant growth in-
vivo between 5 and 10 days after infection, thus indicat-
ing a persistent viable mycobacterial infection compared
to the wild type and complemented strains, which
showed only very moderate growth. Ten days after
infection the mutant had multiplied more than 100
fold and all the infected larvae were dead at the end of
the experiment. Interestingly, the in-vivo growth pattern
of the MAH lysX mutant and wild type in Galleria were
also comparable to the growth pattern observed in-vitro
in HBDM in so far as the mutant showed increased
growth at the later time points of infection [28]. This
phenotype is coherent with our proteomics data which
hitherto revealed that the LysX deficiency in MAH
arouses a metabolic alteration which represents an intra-
cellular metabolic status found in MTB, thereby equip-
ping the bacteria for intracellular niches of the host
organism [28]. In particular, the gene class of ESX export
systems which play a pivotal role in mycobacterial viru-
lence [60] (EccA3, MAV_4606, MAV_0940) and those
involved in anti-apoptotic pathways (CysK [61], KatG
[62], NuoG [63]) were also differentially regulated in the
lysXmut strain.
The lysX mutant from MTB exposed an opposite
phenotype by displaying a growth defect in mouse
and guinea pig lungs and reduced pathology relative
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to wild type [26]. Glycopeptidolipids (GPLs) are major
cell wall constituents of M. avium and other NTM
species but MTB and M. leprae are devoid of them
[64]. It has been hypothesized that the GPLs play
important roles in MAC infections [24] and are
involved in immunomodulatory activities by influen-
cing cytokine induction [64] and promoting phagocy-
tosis by inhibiting phagosome-lysosome fusion. Recent
studies report that the macrophages infected
with M. avium expressing a deficient GPL expression
produce more cytokines and inflammatory chemokines
like TNF-α, IL-6, IL-12p40, and RANTES [65]. Thus,
the elevated inflammatory response induced by the lysX
mutant strain may also be linked to the GPL expression
pattern.
Differential expression of GPLs on the surface of
mycobacteria might also be a phenotypic feature
accounting for the different effects on host immune
responsiveness as they possess the ability to interact
with cell membranes [66,67]. Likewise, variations in
GPL structure affect the pathogenicity of MAC organ-
ism [24].
In summary, the lysX gene from MAH was observed
to play a role in the modulation of mycobacterial viru-
lence which contributes knowledge toward the patho-
physiology of MAH and its interaction with the host.
The study also sheds light on fundamental differences
between MTB and M. avium in terms of their survival
strategies.
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